These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23851485)

  • 1. Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.
    Reynolds AR; Bolin BL; Stoops WW; Rush CR
    Behav Pharmacol; 2013 Sep; 24(5-6):523-32. PubMed ID: 23851485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior?
    Bolin BL; Reynolds AR; Stoops WW; Rush CR
    Behav Pharmacol; 2013 Sep; 24(5-6):533-42. PubMed ID: 23881044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.
    Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH
    Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar discriminative-stimulus effects of D-amphetamine in women and men.
    Vansickel AR; Lile JA; Stoops WW; Rush CR
    Pharmacol Biochem Behav; 2007; 87(2):289-96. PubMed ID: 17561238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    Sevak RJ; Stoops WW; Hays LR; Rush CR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.
    Smith CT; Weafer J; Cowan RL; Kessler RM; Palmer AA; de Wit H; Zald DH
    J Psychopharmacol; 2016 Apr; 30(4):330-43. PubMed ID: 26880226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.
    Hamidovic A; Childs E; Conrad M; King A; de Wit H
    Drug Alcohol Depend; 2010 Jun; 109(1-3):175-80. PubMed ID: 20176450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW; Glaser PE; Fillmore MT; Rush CR
    J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.
    Sevak RJ; Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2010 Jul; 36(4):220-7. PubMed ID: 20560842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
    Kollins SH; Rush CR
    Pharmacol Biochem Behav; 1999 Oct; 64(2):319-26. PubMed ID: 10515308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute behavioral and physiological effects of modafinil in drug abusers.
    Rush CR; Kelly TH; Hays LR; Baker RW; Wooten AF
    Behav Pharmacol; 2002 Mar; 13(2):105-15. PubMed ID: 11981223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.
    Lile JA; Babalonis S; Emurian C; Martin CA; Wermeling DP; Kelly TH
    J Clin Pharmacol; 2011 Jun; 51(6):888-98. PubMed ID: 20671295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
    Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
    Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.